Alan Huang
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Alan Huang
The proxy statement of Tango Therapeutics, Inc. reports total compensation of $1,770,905 for Alan Huang in fiscal 2023, including a base salary of $350,615. Disclosed compensation is on record for 4 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Tango Therapeutics, Inc. (TNGX)
Proxy statement
Start not stated–2023-04-24
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Tango Therapeutics, Inc. (TNGX) | Former Chief Scientific Officer | $350,615 | $1,770,905 |
| 2022 | Tango Therapeutics, Inc. (TNGX) | Former Chief Scientific Officer | $425,385 | $1,818,901 |
| 2021 | Tango Therapeutics, Inc. (TNGX) | Chief Scientific Officer | $394,793 | $2,215,657 |
| 2020 | Tango Therapeutics, Inc. (TNGX) | Chief Scientific Officer | $373,806 | $589,517 |
Recent activity
No call appearances or filed executive changes recorded yet.